ExodusPoint Capital Management, LP

Position in MLYS — Mineralys Therapeutics, Inc.

CIK 1736225 NEW YORK, NY

Position in MLYS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,726,382

+$2,473,456 QoQ

Shares Held

101,052

+1415.0% QoQ

Ownership

0.114%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#83

of 224 holders

Holding Since

Mar 2023

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ExodusPoint Capital Management, LP holds $275,349,927 across 101 Biotechnology names. MLYS ranks #32 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CYTK	Cytokinetics Inc	249,259	$21,234,374
2	BBIO	BridgeBio Pharma, Inc.	224,927	$16,752,562
3	ORKA	Oruka Therapeutics, Inc.	148,212	$14,105,336
4	VKTX	Viking Therapeutics, Inc.	361,126	$14,087,525
5	JAZZ	Jazz Pharmaceuticals plc	53,201	$12,819,844
6	NAMS	NewAmsterdam Pharma Co N.V.	304,334	$10,313,879
7	TGTX	Tg Therapeutics, Inc.	164,513	$9,038,344
8	DNLI	Denali Therapeutics Inc.	336,567	$8,656,503

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,726,382	101,052	+1415.0%	Shares	Sole	2026-08-14
2025-09-30	$252,926	6,670	-96.1%	Shares	Sole	2025-11-14
2025-06-30	$2,334,628	172,552	-37.1%	Shares	Sole	2025-08-13
2024-06-30	$3,209,497	274,316	+124.5%	Shares	Sole	2024-08-13
2024-03-31	$1,577,679	122,206	+65.3%	Shares	Sole	2024-05-14
2023-12-31	$635,884	73,940	-53.6%	Shares	Sole	2024-02-14
2023-09-30	$1,516,283	159,441	-17.6%	Shares	Sole	2023-11-13
2023-06-30	$3,299,601	193,525	+6.7%	Shares	Sole	2023-08-11
2023-03-31	$2,839,345	181,312	—	Shares	Sole	2023-05-11
No filing history on record for this holder in this stock.